Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CompuMed, Inc. stock logo
CMPD
CompuMed
$1.70
$1.69
$1.48
$3.43
$2.18M0.28456 shsN/A
Akerna Corp. stock logo
KERN
Akerna
$5.89
$0.17
$6.40
$64.92M3.02339,022 shs70,795 shs
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
$0.00
-6.3%
$0.00
$0.00
$0.01
$1.42M3.262.40 million shs344,125 shs
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
$0.41
$0.59
$0.00
$14.00
$3.64M0.673,784 shs5,643 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CompuMed, Inc. stock logo
CMPD
CompuMed
0.00%0.00%+0.59%-11.46%-37.27%
Akerna Corp. stock logo
KERN
Akerna
0.00%0.00%0.00%-7.49%-58.22%
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
0.00%-30.43%-33.33%-46.67%-71.93%
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
0.00%-19.61%-28.07%-57.29%-91.81%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CompuMed, Inc. stock logo
CMPD
CompuMed
N/AN/AN/AN/AN/AN/AN/AN/A
Akerna Corp. stock logo
KERN
Akerna
N/AN/AN/AN/AN/AN/AN/AN/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/AN/AN/AN/AN/AN/AN/AN/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CompuMed, Inc. stock logo
CMPD
CompuMed
N/AN/AN/AN/A
Akerna Corp. stock logo
KERN
Akerna
N/AN/AN/AN/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/AN/AN/AN/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
N/AN/A$20.004,778.05% Upside

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CompuMed, Inc. stock logo
CMPD
CompuMed
$5.84M0.37$0.51 per share3.36$2.42 per share0.70
Akerna Corp. stock logo
KERN
Akerna
$13.65M0.00N/AN/A($1.52) per share0.00
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
$400K3.54N/AN/A($0.01) per share-0.15
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
$50.29M0.07N/AN/A$11.52 per share0.04

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CompuMed, Inc. stock logo
CMPD
CompuMed
-$30K-$0.03N/AN/A-0.85%-1.49%-1.09%5/3/2024 (Estimated)
Akerna Corp. stock logo
KERN
Akerna
-$79.06M-$7.10N/AN/AN/A-339.99%N/A-113.03%N/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
-$6.13MN/A0.00N/A-1,888.47%-202.89%-598.61%N/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
-$34.11M-$8.21N/AN/A-64.71%-136.40%-43.70%4/30/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CompuMed, Inc. stock logo
CMPD
CompuMed
N/AN/AN/AN/AN/A
Akerna Corp. stock logo
KERN
Akerna
N/AN/AN/AN/AN/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/AN/AN/AN/AN/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CompuMed, Inc. stock logo
CMPD
CompuMed
0.07
2.70
2.31
Akerna Corp. stock logo
KERN
Akerna
N/A
0.10
0.10
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/AN/AN/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
1.38
1.88
1.03

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CompuMed, Inc. stock logo
CMPD
CompuMed
N/A
Akerna Corp. stock logo
KERN
Akerna
21.97%
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
N/A

Insider Ownership

CompanyInsider Ownership
CompuMed, Inc. stock logo
CMPD
CompuMed
22.00%
Akerna Corp. stock logo
KERN
Akerna
1.20%
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
3.81%
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
8.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CompuMed, Inc. stock logo
CMPD
CompuMed
81.28 million995,000Not Optionable
Akerna Corp. stock logo
KERN
Akerna
11210.35 million10.23 millionNo Data
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
2943.17 million907.24 millionNot Optionable
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
1748.88 million8.12 millionNot Optionable

MGTI, CMPD, KERN, and UTRS Headlines

SourceHeadline
Minerva Surgical (NASDAQ:UTRS) Trading Down 8.9%Minerva Surgical (NASDAQ:UTRS) Trading Down 8.9%
americanbankingnews.com - April 18 at 1:52 AM
Minerva Surgical Inc.Minerva Surgical Inc.
thestreet.com - January 10 at 7:34 AM
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
markets.businessinsider.com - December 18 at 10:26 AM
Minerva Surgical Inc UTRSMinerva Surgical Inc UTRS
morningstar.com - December 17 at 10:33 PM
Minerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial ResultsMinerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial Results
finanznachrichten.de - November 14 at 4:08 PM
Minerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93MMinerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93M
msn.com - November 14 at 4:08 PM
Minerva Surgical Reports Third Quarter 2023 Financial ResultsMinerva Surgical Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 13 at 7:07 PM
Accelmed Files Transaction Statement on Schedule 13E-3 with Securities and Exchange CommissionAccelmed Files Transaction Statement on Schedule 13E-3 with Securities and Exchange Commission
finance.yahoo.com - September 29 at 2:06 PM
Minerva Surgical Inc (UTRS) Becoming More Attractive for InvestorsMinerva Surgical Inc (UTRS) Becoming More Attractive for Investors
knoxdaily.com - September 27 at 2:11 PM
UTRS Shares Experience Surge in ValueUTRS Shares Experience Surge in Value
knoxdaily.com - August 25 at 6:42 PM
Minerva Surgical Reports Second Quarter 2023 Financial ResultsMinerva Surgical Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 3 at 10:06 AM
Minerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue EstimatesMinerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 3 at 10:06 AM
Investors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past weekInvestors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past week
finance.yahoo.com - May 25 at 10:50 AM
Patent Grant Sends Healthcare Shares Soaring PremarketPatent Grant Sends Healthcare Shares Soaring Premarket
theglobeandmail.com - May 24 at 1:56 PM
Why Minerva Surgical Shares Are Taking Off WednesdayWhy Minerva Surgical Shares Are Taking Off Wednesday
msn.com - May 24 at 1:56 PM
Why Is Minerva Surgical (UTRS) Stock Up 229% Today?Why Is Minerva Surgical (UTRS) Stock Up 229% Today?
msn.com - May 24 at 8:56 AM
Q1 2023 Minerva Surgical Inc Earnings CallQ1 2023 Minerva Surgical Inc Earnings Call
finance.yahoo.com - May 3 at 9:37 AM
Minerva Surgical Reports First Quarter 2023 Financial ResultsMinerva Surgical Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 2 at 8:01 PM
Modified Minerva orthosis proven helpful in pediatric patients following airway surgeryModified Minerva orthosis proven helpful in pediatric patients following airway surgery
medicalxpress.com - May 2 at 10:00 AM
Minerva Surgical to Announce First Quarter 2023 Financial ResultsMinerva Surgical to Announce First Quarter 2023 Financial Results
finance.yahoo.com - April 18 at 6:52 PM
Minerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call TranscriptMinerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 24 at 9:32 AM
Piper Sandler Remains a Buy on Minerva Surgical (UTRS)Piper Sandler Remains a Buy on Minerva Surgical (UTRS)
markets.businessinsider.com - March 23 at 2:05 PM
Minerva Surgical Stock (NASDAQ:UTRS), DividendsMinerva Surgical Stock (NASDAQ:UTRS), Dividends
benzinga.com - March 22 at 7:18 PM
Minerva Surgical, Inc.: Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial ResultsMinerva Surgical, Inc.: Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial Results
finanznachrichten.de - March 22 at 9:01 AM

New MarketBeat Followers Over Time

Company Descriptions

CompuMed logo

CompuMed

OTCMKTS:CMPD
CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.
Akerna logo

Akerna

NASDAQ:KERN
Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.
MGT Capital Investments logo

MGT Capital Investments

OTCMKTS:MGTI
MGT Capital Investments, Inc. engages in cryptocurrency mining business in the United States. It also leases space to other bitcoin miners; and provides hosting services for owners of mining equipment. The company was incorporated in 1977 and is headquartered in Raleigh, North Carolina.
Minerva Surgical logo

Minerva Surgical

NASDAQ:UTRS
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.